Journal
STEM CELL REPORTS
Volume 12, Issue 3, Pages 518-531Publisher
CELL PRESS
DOI: 10.1016/j.stemcr.2019.01.020
Keywords
-
Categories
Funding
- National Research Foundation of Korea - Korea Government [NRF-2017M3A9C6029306]
- Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI16C1176]
Ask authors/readers for more resources
Recent advances in generating three-dimensional (3D) organoid systems from stem cells offer new possibilities for disease modeling and drug screening because organoids can recapitulate aspects of in vivo architecture and physiology. In this study, we generate isogenic 3D midbrain organoids with or without a Parkinson's disease-associated LRRK2 G2019S mutation to study the pathogenic mechanisms associated with LRRK2 mutation. We demonstrate that these organoids can recapitulate the 3D pathological hallmarks observed in patients with LRRK2-associated sporadic Parkinson's disease. Importantly, analysis of the protein-protein interaction network in mutant organoids revealed that TXNIP, a thiol-oxidoreductase, is functionally important in the development of LRRK2-associated Parkinson's disease in a 3D environment. These results provide proof of principle for the utility of 3D organoid-based modeling of sporadic Parkinson's disease in advancing therapeutic discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available